UnitedHealth CFO granted stock and option awards

DeVeydt Wayne S reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

DeVeydt Wayne S reported acquisition or exercise transactions in this Form 4 filing.

UnitedHealth Group’s Chief Financial Officer Wayne S. DeVeydt reported equity awards that increase his direct ownership in the company. He was granted non-qualified stock options for 35,517 shares on February 23, 2026, and a separate award of 8,855 shares of common stock at $282.34 per share.

The common stock award and related restricted stock units vest in 25% increments each February 23 from 2027 through 2030. The stock options follow the same vesting schedule, also vesting 25% annually on those dates. These awards are classified as grants or awards rather than open-market purchases.

Insider Trade Summary

Grant/Award: 44,372 shares

Grant/Award 2 txns

Insider DeVeydt Wayne S

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Non-Qualified Stock Options (right to buy)	35,517	$0.00	$0.00
Grant/Award	Common Stock	8,855	$282.34	$2.50M

Holdings After Transaction: Non-Qualified Stock Options (right to buy) — 35,517 contracts (Direct); Common Stock — 19,516.941 shares (Direct)

Footnotes (2)

1. F1. The restricted stock units vest at a rate of 25% annually on February 23 from the years 2027 through 2030.
2. F2. The non-qualified stock options vest at a rate of 25% annually on February 23 from the years 2027 through 2030.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did UnitedHealth Group (UNH) CFO Wayne DeVeydt report on this Form 4?

UnitedHealth Group’s CFO Wayne DeVeydt reported receiving new equity awards. He was granted 35,517 non-qualified stock options and 8,855 shares of common stock, both as part of grant or award transactions rather than open-market purchases, increasing his direct equity exposure.

How many stock options were granted to the UnitedHealth (UNH) CFO?

Wayne DeVeydt received 35,517 non-qualified stock options. These options were granted on February 23, 2026 and vest in equal 25% installments on February 23 of each year from 2027 through 2030, aligning vesting with a four-year service period.

How many UnitedHealth (UNH) common shares were awarded to the CFO and at what price?

The CFO was awarded 8,855 shares of UnitedHealth common stock at a grant price of $282.34 per share. This award is classified as an acquisition by grant or award, not an open-market purchase, and contributes to his overall direct holdings in the company.

What is the vesting schedule for Wayne DeVeydt’s UnitedHealth (UNH) stock awards?

Both the restricted stock units tied to the common stock award and the non-qualified stock options vest 25% annually. Vesting occurs each February 23 from 2027 through 2030, creating a four-year vesting horizon linked to continued service with UnitedHealth Group.

Are Wayne DeVeydt’s UnitedHealth (UNH) Form 4 transactions open-market buys or grants?

The transactions are grants or awards, not open-market buys. The filing classifies both the 35,517 stock options and 8,855 common shares as acquisitions under a grant or award code, reflecting compensation-related equity rather than discretionary stock purchases in the market.

How many UnitedHealth (UNH) shares does the CFO hold after the reported common stock grant?

Following the 8,855-share common stock award, Wayne DeVeydt directly holds 19,516.941 UnitedHealth common shares. This figure reflects his updated direct ownership position after the grant reported in the Form 4, excluding the separate non-qualified stock option award.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/25/2026 - 04:07 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DeVeydt Wayne S

(Last) (First) (Middle)

C/O UNITEDHEALTH GROUP INCORPORATED

1 HEALTH DRIVE

(Street)

EDEN PRAIRIE MN 55344

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/23/2026		A		8,855(1)	A	$282.34	19,516.941	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Options (right to buy)	$282.34	02/23/2026		A		35,517		(2)	02/23/2036	Common Stock	35,517	$0	35,517	D

Explanation of Responses:

1. The restricted stock units vest at a rate of 25% annually on February 23 from the years 2027 through 2030.

2. The non-qualified stock options vest at a rate of 25% annually on February 23 from the years 2027 through 2030.

Remarks:

	Faraz A. Choudhry, Attorney-in-Fact for Wayne S. DeVeydt	02/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.